For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of Vyndamax and Attruby represents a genuine advancement . These groundbreaking therapies stabilize the transthyretin protein, preventing its destructive build-up and reducing the severity of the illness. People are now seeing positive outcome… Read More